Can vertical farming play a roll in healthcare? The team with iBio, Inc. for sure thinks so. The biotech innovator and biologics contract manufacturing organization, today announced that management will participate in Alliance Global Partners’ Virtual Healthcare Symposium on November 19, 2020.

iBio is a player in plant-based biologics manufacturing. Its FastPharming® System combines vertical farming, automated hydroponics, and glycan engineering technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins.

"In addition to participating in a series of one-on-one meetings with institutional investors throughout the day, we will participate on a panel hosted by Jim Molloy, Alliance Global Partners’ Managing Director, Equity Research Biotechnology & Specialty Pharmaceuticals, entitled “The Next Wave in COVID-19 Treatments: After PFE, AZN, MRNA & the Rest, What Should we Look for in the Next Set of COVID-19 Diagnostics and Treatments?”," they say. 

Due to the format of the event, no webcast will be available.

For more information:

Stephen Kilmer
iBio, Inc.
Investor Relations
+1 (646) 274-3580